BioWorld MedTech: “Chromacode looks to battle tickborne pathogens with new assay”
ChromaCode to Present at the 30th Annual Piper Jaffray Healthcare Conference
November 19, 2018Genome Web: “ChromaCode Tackling Tick-Bourne Illness Testing With Multiplex Molecular Panel”
December 11, 2018BioWorld Medtech reporter Liz Hollis has published a feature article – the top in the December 11th issue – on ChromaCode’s first-to-the-market HDPCR product: Tick-Borne Pathogen Panel (RUO).
BioWorld Medtech is one of the top medical device industry trades, with a subscription audience of approx. 18,500, focused on providing insight and information such as new product developments, company news, regulatory activity, legislative actions, strategic alliances, sales and mergers and market updates.